Scientists have discovered a method to disrupt the production of infectious virus particles that cause hepatitis C, a blood-borne liver disease. This discovery might be a first step in developing new and more effective therapies against the hepatitis C virus. Current anti-virals are ineffective for the majority of patients infected with the viral strains most prevalent in the United States.